Peptide Sciences Alternative 2026: Where to Source BPC-157, TB-500, and GHK-Cu After the Shutdown

This article is for informational purposes only. It is written for qualified researchers and laboratory purchasers evaluating replacement suppliers for research-grade peptides following the closure of Peptide Sciences in March 2026. It does not constitute medical, legal, or financial advice. All compounds referenced are sold by MOG Research strictly for laboratory research use — not for human or animal administration.

TL;DR

Peptide Sciences (peptidesciences.com) ceased operations in early March 2026, ending what had been the largest US-facing research peptide supplier by traffic and order volume.
Researchers who relied on Peptide Sciences for BPC-157, TB-500, GHK-Cu, MT-2, Epitalon, and Retatrutide are now sourcing from a fragmented post-shutdown landscape.
This guide outlines what to evaluate in a replacement supplier — purity verification, batch-specific COAs, US-based fulfillment, and compliant RUO framing — and identifies MOG Research as one option that carries Peptide Sciences’ top five compounds with HPLC + MS-verified purity at ≥99%.

What Happened to Peptide Sciences

Peptide Sciences operated as a US-facing research peptide supplier from approximately 2013 through early 2026. Public web archive data and industry coverage place the formal cessation of operations on or around March 6, 2026, when the company’s storefront stopped processing new orders and the catalog was removed. Order fulfillment for outstanding shipments was reported to have continued for several weeks afterward before the customer support channels also went dark.

The reasons for the shutdown have not been publicly stated by the company. Industry observers have pointed to the broader 2025–2026 regulatory environment — including FDA enforcement activity against several other gray-market peptide vendors during the same period — as part of the context, but no official statement from Peptide Sciences has confirmed any specific trigger.

At the time of shutdown, third-party analytics estimated Peptide Sciences at roughly 990,000 monthly site visits. That volume of researchers, lab purchasers, and individual buyers is now distributed across a smaller number of remaining suppliers, none of which inherited the customer base cleanly. The resulting market is more fragmented than it was in 2025, and more researchers are spending time vetting unfamiliar vendors than at any point in the recent history of the niche.

Why This Matters for Researchers

For laboratory programs that built standard operating procedures around a single supplier’s lot numbers, COA formats, and reconstitution protocols, a sudden vendor disappearance is a real operational disruption. Replacing a vendor is not just placing an order with someone new — it involves re-validating purity profiles, updating internal documentation, and in some cases revising study protocols to account for any source-related variability in batch-to-batch peptide identity.

The post-Peptide Sciences market has three notable characteristics that affect supplier selection:

Surge in low-quality entrants. New peptide storefronts appeared rapidly during March–May 2026 attempting to capture displaced demand. Many of these operate without verifiable third-party testing.
Reputational pressure on incumbents. Vendors that did not receive FDA scrutiny in 2025–2026 are now seeing increased order volume, which has stressed the fulfillment and quality control systems of some operators.
Confusion about regulatory framing. Researchers are encountering inconsistent “research use only” disclaimers, conflicting purity claims, and varying levels of COA transparency across the remaining vendor pool.

A careful evaluation framework is more important now than it was in 2025.

What to Look for in a Replacement Supplier

The criteria below are the operational checks experienced laboratory purchasers apply when onboarding a new research peptide vendor. None of these are unique to MOG Research or to peptides — they are the same standards applied to any research chemical procurement.

1. HPLC Purity Verification at ≥99%

High-Performance Liquid Chromatography (HPLC) is the standard analytical method for confirming peptide purity. Research-grade material should report ≥99% purity by HPLC. Numbers below 98% indicate either lower-grade material or batch variability that is unsuitable for sensitive research applications.

2. Mass Spectrometry Confirmation of Identity

Purity alone does not confirm molecular identity. Mass spectrometry (MS) — typically reported alongside HPLC on the Certificate of Analysis — confirms that the peptide synthesized matches the expected molecular weight for the target sequence. A COA listing only HPLC purity without an MS trace is incomplete.

3. Batch-Specific COA Per Lot

A single “company-wide” COA file is a red flag. Each manufacturing lot produces a distinct peptide sample with its own purity profile, endotoxin reading, and testing date. Reputable suppliers issue a unique COA per batch and link that batch number to the specific vial(s) shipped to the researcher. The COA should be downloadable or accessible by lot number.

4. Endotoxin Testing (LAL)

For applications involving cell culture, in vivo work, or any preparation where bacterial endotoxin contamination would compromise results, the COA should include LAL (Limulus Amebocyte Lysate) endotoxin testing below the standard research-grade threshold. This is a less universally reported metric, but its presence on a COA is a signal of higher manufacturing standards.

5. US-Based Fulfillment

Domestic manufacturing and shipping reduce transit time, eliminate customs holds, and provide a clearer chain of custody. Suppliers that warehouse and ship from inside the United States typically deliver within 2–4 business days and avoid the freeze-thaw cycles associated with international shipping delays.

6. Reasonable, Transparent Pricing

Pricing significantly below the market median is often a leading indicator of either substandard material or unsustainable operations that will exit the market quickly. Pricing significantly above market without corresponding documentation of additional testing or purity is not justified. Reasonable suppliers price BPC-157 5mg in the $35–$50 range, BPC-157 10mg in the $60–$80 range, and GHK-Cu 50mg in the $40–$60 range as of mid-2026.

7. Compliant RUO Framing

The vendor’s site language matters. Suppliers that imply human dosing, suggest therapeutic outcomes, or use clinical language are signaling either regulatory naivety or willingness to operate outside the RUO framework. Both are risks. Compliant vendors use research-context language throughout and place visible “Research Use Only” disclaimers on every product page.

8. Functional Customer Support and Documentation

Replying within one business day, responding to COA requests, and providing handling and storage documentation are basic operational signals. A supplier whose support email bounces or whose contact form does not generate a reply is not a supplier you can rely on for reorders during an active research program.

MOG Research as a Replacement Option

MOG Research is a US-based research peptide supplier operating from domestic manufacturing and fulfillment. The catalog currently includes the five compounds most frequently sourced from Peptide Sciences prior to its closure: BPC-157, TB-500, GHK-Cu, Melanotan II (MT-2), and Retatrutide. Each is supplied as a lyophilized powder, ≥99% HPLC-verified purity, with a batch-specific Certificate of Analysis available per lot.

Operational standards:

Purity: ≥99% HPLC verified, mass spectrometry confirmed
Endotoxin: LAL tested per batch, below standard research-grade threshold
Storage at fulfillment: -20°C cold-chain through ship-out
Shipping: Same-day fulfillment for orders placed before 2:00 PM ET; 2–4 business day USPS Priority delivery within the United States
COA access: Batch-specific PDF linked from each product page and printed with each order
Support: Email reply within one business day at office@mogresearch.com

MOG Research is not making a claim to be a 1-for-1 replacement for any prior supplier. The position offered here is that the catalog overlap, purity standards, and operational profile make MOG Research a viable evaluation candidate for researchers who relied on Peptide Sciences’ BPC-157, TB-500, GHK-Cu, MT-2, or Retatrutide.

Compound-by-Compound Replacement Guide

The five most-ordered compounds at Peptide Sciences (based on independent third-party traffic analysis of category pages prior to shutdown) and their direct equivalents in the MOG Research catalog:

BPC-157

A 15-amino-acid synthetic peptide (sequence: GEPPPGKPADDAGLV; CAS: 137525-51-0; MW: 1419.5 g/mol) extensively studied in preclinical models for angiogenic signaling, nitric oxide modulation, and gastrointestinal cytoprotection. Available from MOG Research in 5mg and 10mg lyophilized vials. See the BPC-157 product page and the BPC-157 mechanism of action review.

TB-500

A synthetic fragment of Thymosin Beta-4 (full TB-4 CAS: 77591-33-4) studied in preclinical literature for actin regulation and systemic tissue repair signaling. Available in 5mg and 10mg lyophilized vials. See the TB-500 product page.

GHK-Cu

A copper-bound tripeptide (Glycine-Histidine-Lysine + Cu²⁺; CAS: 49557-75-7) studied in preclinical models for collagen synthesis signaling, fibroblast activation, and extracellular matrix research. Available in 50mg and 100mg lyophilized vials. See the GHK-Cu product page.

Melanotan II (MT-2)

A cyclic heptapeptide analogue of α-melanocyte stimulating hormone (α-MSH; CAS: 121062-08-6) studied for melanocortin receptor agonism in preclinical pigmentation research. Available in 10mg lyophilized vials. See the MT-2 product page.

Retatrutide

A novel triple agonist (LY3437943) of the GLP-1, GIP, and glucagon receptors, studied in preclinical metabolic research. Available in 10mg and 20mg lyophilized vials. See the Retatrutide product page.

What MOG Research Does Not Currently Carry

For transparency, the following compounds that were available at Peptide Sciences are not part of the current MOG Research catalog: Epitalon, CJC-1295, Ipamorelin, Sermorelin, MOTS-C, Humanin, Selank, Semax, and several less-common compounds. Researchers who require these compounds in the same order as the five listed above may need to source from multiple suppliers in the near term. MOG Research catalog expansion is under active evaluation based on researcher demand; questions or compound requests can be directed to office@mogresearch.com.

Frequently Asked Questions

When did Peptide Sciences shut down?

Peptide Sciences ceased accepting new orders on or around March 6, 2026. The storefront catalog was removed shortly afterward, and customer support channels went unresponsive over the following weeks.

Has Peptide Sciences reopened or relocated?

As of May 19, 2026, there is no public indication that Peptide Sciences has resumed operations under the original brand or relocated to a new domain. Researchers should be cautious of new sites claiming to be the “official” continuation — none have been publicly confirmed.

Is MOG Research’s BPC-157 the same as Peptide Sciences’ BPC-157?

BPC-157 is the same molecule regardless of supplier — a synthetic pentadecapeptide with sequence GEPPPGKPADDAGLV. Sourcing the same compound from a different manufacturer means working with a different batch, a different COA, and potentially a different purity profile at the margins. MOG Research’s BPC-157 is supplied at ≥99% HPLC-verified purity with batch-specific COA, which is the same standard Peptide Sciences claimed on its product pages.

Can I trust the COAs from a new supplier?

A COA from a reputable laboratory will include the testing facility’s name, the testing date, the batch number, the analytical methods used, and the specific results. If any of those four fields are absent — or if the COA is unsigned and undated — verify directly with the supplier before placing a research order. MOG Research COAs include all four fields.

Are there other reputable peptide suppliers besides MOG Research?

Yes. The remaining post-Peptide Sciences vendor landscape includes several established US-based suppliers. Researchers should apply the same evaluation criteria to any vendor under consideration — purity verification, batch-specific COAs, US fulfillment, RUO framing, and operational responsiveness. This article is not a claim that MOG Research is the only option, only that it is a viable one for the catalog overlap described above.

Continue Reading

All compounds discussed in this article are sold by MOG Research for laboratory and scientific research purposes only. They are not intended for human or animal consumption, are not drugs, are not FDA approved, and are not for therapeutic use. References to other suppliers in this article are based on publicly available information and are provided for informational comparison only; no endorsement or affiliation is implied. Qualified researchers operating in compliant laboratory environments are the intended audience for this material.